Stock Market Live July 2, 2026: S&P 500 (SPY) Flat with New Jobs Data

Investing

Johnson & Johnson : JNJ

All Johnson & Johnson Articles

1243 Articles

Jon C. Ogg | Jan 15, 2015 at 8:45 AM EST

Top Analyst Upgrades and Downgrades: Apple, Barrick Gold, Corning, Groupon, Peabody, SolarCity and More

Thursday's top analyst upgrades, downgrades include Apple, Barrick Gold, Corning, Groupon, Peabody Energy and SolarCity.

Lee Jackson | Jan 12, 2015 at 8:50 AM EST

Analyst’s Top Stock Picks for 2015 That Are Unloved by Wall Street

Cowen has a long list of stocks that are out of favor at many other firms on Wall Street. These…

Jon C. Ogg | Jan 8, 2015 at 8:15 AM EST

The Bullish and Bearish Case for Johnson & Johnson in 2015

One key consideration for the year ahead is that Johnson & Johnson raised its dividends again and managed to have…

Paul Ausick | Nov 18, 2014 at 9:10 AM EST

Companies Spending the Most on R&D

For the third consecutive year, the company spending the most on research and development (R&D) was Germany's Volkswagen.

Jon C. Ogg | Nov 14, 2014 at 4:58 PM EST

Significant Changes in Buffett and Berkshire Hathaway Holdings

courtesy of WhiteHouse.govBerkshire Hathaway Inc. (NYSE: BRK-A) has released its public equity holdings as of September 30, 2014. Warren Buffett’s…

Chris Lange | Nov 14, 2014 at 11:35 AM EST

What Licensing Imetelstat Will Mean for Geron

Geron hasannounced that it entered into an exclusive worldwide license and collaboration agreement with Janssen Biotech to develop and commercialize…

Paul Ausick | Nov 4, 2014 at 4:01 PM EST

The 4 DJIA Stocks Leading the Market to a Mixed Close

thinkstockNovember 4, 2014: Markets opened slightly lower on Tuesday as the bottom fell out on crude oil which went on…

Paul Ausick | Oct 14, 2014 at 4:01 PM EDT

The 4 DJIA Stocks That Kept the Index Flat

thinkstockOctober 14, 2014: Markets opened higher on Tuesday and had put up a nice gain by noon. Then the wheels…

Paul Ausick | Oct 14, 2014 at 9:05 AM EDT

Drug Sales Energize Johnson & Johnson Earnings

Johnson & Johnson reported better-than-expected third-quarter 2014 results before markets opened Tuesday.

Jon C. Ogg | Oct 10, 2014 at 8:30 AM EDT

Top Analyst Upgrades and Downgrades: EMC, IBM, Procera Networks, Wayfair, Yelp and More

These are the top analyst upgrades and downgrades featured by 24/7 Wall St. for Friday, October 10, 2014.

Paul Ausick | Oct 7, 2014 at 4:01 PM EDT

The 4 Stocks That Tanked the Market

thinkstockOctober 7, 2014: Markets opened lower on Tuesday and never even took a serious run at the break-even line. The…

Lee Jackson | Oct 2, 2014 at 8:55 AM EDT

Makers of the 10 Top-Selling Cancer Drugs Catch the Eye of Analyst

The data is grim: cancer is increasing. Sales of these top oncology drugs are likely to increase as well.

Jon C. Ogg | Sep 29, 2014 at 4:05 PM EDT

The Best- and Worst-Performing DJIA Stocks in 2014

The bull market may be five and a half years old, but stocks have been fighting each week to hit…

Paul Ausick | Sep 29, 2014 at 4:01 PM EDT

The 4 Stocks That Weighed on the Market

thinkstockSeptember 29, 2014: Markets opened lower on Monday as concern related to the demonstrations in Hong Kong and a coming…

Jon C. Ogg | Sep 24, 2014 at 6:45 AM EDT

The Best Performing DJIA Stocks of 2014

The bull market may be five and a half years old, but stocks have been fighting each week to hit…

1 … 48 49 50 51 52 … 83

Johnson & Johnson : JNJ

All Johnson & Johnson Articles

Top Analyst Upgrades and Downgrades: Apple, Barrick Gold, Corning, Groupon, Peabody, SolarCity and More

Analyst’s Top Stock Picks for 2015 That Are Unloved by Wall Street

The Bullish and Bearish Case for Johnson & Johnson in 2015

Companies Spending the Most on R&D

Significant Changes in Buffett and Berkshire Hathaway Holdings

What Licensing Imetelstat Will Mean for Geron

The 4 DJIA Stocks Leading the Market to a Mixed Close

The 4 DJIA Stocks That Kept the Index Flat

Drug Sales Energize Johnson & Johnson Earnings

Top Analyst Upgrades and Downgrades: EMC, IBM, Procera Networks, Wayfair, Yelp and More

The 4 Stocks That Tanked the Market

Makers of the 10 Top-Selling Cancer Drugs Catch the Eye of Analyst

The Best- and Worst-Performing DJIA Stocks in 2014

The 4 Stocks That Weighed on the Market

The Best Performing DJIA Stocks of 2014

Stock Market Live July 2, 2026: S&P 500 (SPY) Flat with New Jobs Data

Palantir CEO: “Something Has Gone Completely Wrong” In AI. Alex Karp Says Enterprises Are Paying To Lose Their Competitive Edge

Micron’s CEO Says Even His Own Customers Couldn’t See This Coming. Now He’s Spending $200 Billion

Reddit Vs. Chewy: The Better Buy Stock In 2026

Dividend Aristocrats Are Quietly Outrunning Software in 2026. Investors Are Piling Into This ETF

$900,000 Inherited 401(k): The 10-Year Tax Bomb Most Beneficiaries Miss Until Year 10

Airlines Get a Wall Street Lift as Goldman, TD Cowen Raise Targets on Delta, United, Southwest, American

Skyrocketing Beef Prices Will Make This The Most Expensive Fourth Of July Cookout In History

Johnson & Johnson : JNJ

All Johnson & Johnson Articles

Top Analyst Upgrades and Downgrades: Apple, Barrick Gold, Corning, Groupon, Peabody, SolarCity and More

Analyst’s Top Stock Picks for 2015 That Are Unloved by Wall Street

The Bullish and Bearish Case for Johnson & Johnson in 2015

Companies Spending the Most on R&D

Significant Changes in Buffett and Berkshire Hathaway Holdings

What Licensing Imetelstat Will Mean for Geron

The 4 DJIA Stocks Leading the Market to a Mixed Close

The 4 DJIA Stocks That Kept the Index Flat

Drug Sales Energize Johnson & Johnson Earnings

Top Analyst Upgrades and Downgrades: EMC, IBM, Procera Networks, Wayfair, Yelp and More

The 4 Stocks That Tanked the Market

Makers of the 10 Top-Selling Cancer Drugs Catch the Eye of Analyst

The Best- and Worst-Performing DJIA Stocks in 2014

The 4 Stocks That Weighed on the Market

The Best Performing DJIA Stocks of 2014

Stock Market Live July 2, 2026: S&P 500 (SPY) Flat with New Jobs Data

Palantir CEO: “Something Has Gone Completely Wrong” In AI. Alex Karp Says Enterprises Are Paying To Lose Their Competitive Edge

Micron’s CEO Says Even His Own Customers Couldn’t See This Coming. Now He’s Spending $200 Billion

Reddit Vs. Chewy: The Better Buy Stock In 2026

Featured Reads

Dividend Aristocrats Are Quietly Outrunning Software in 2026. Investors Are Piling Into This ETF

$900,000 Inherited 401(k): The 10-Year Tax Bomb Most Beneficiaries Miss Until Year 10